Click Here to return To Results

 

Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014 See this aricle in Pubmed Article Abstract Very small but persistent benefits are shown for patient-rated mobility scores when treatment is initiated with levodopa compared with levodopa-sparing therapy. MAOBI as initial levodopa-sparing therapy was at least as effective as dopamine agonists.

Related Tags

(click to filter results - removes previous filter) dopamine agonist efficacy L-dopa monoamine oxidase inhibitors Parkinson disease Parkinson disease,treatment of treatment of neurologic disorder

Click Here to return To Results